BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.358
-0.012 (-3.22%)
At close: Jan 22, 2025, 4:00 PM
0.352
-0.006 (-1.68%)
After-hours: Jan 22, 2025, 4:24 PM EST
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $6.43 million as of January 22, 2025. Its market cap has decreased by -29.25% in one year.
Market Cap
6.43M
Enterprise Value
2.67M
1-Year Change
-29.25%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $6.43M, a decrease of -84.73%. That is a compound annual growth rate of -35.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 6.65M | 32.25% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 207.60B |
| BHP Group | 126.24B |
| Rio Tinto Group | 104.31B |
| The Sherwin-Williams Company | 88.85B |
| Southern Copper | 77.56B |
| Air Products and Chemicals | 70.67B |
| Ecolab | 67.23B |
| CRH plc | 66.20B |